Skip to main content
TRDA
NASDAQ Life Sciences

Entrada Beats on Q3 Loss Per Share but Revenue Collapses 44% to $905K

Tom Rudovsky · Reported by Reuters
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$4.59
Mkt Cap
$178.719M
52W Low
$4.109
52W High
$16.45
52W Position info
12% above low
Off High info
72% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

TRDA is trading near its 52-week low of $4.109 (12% above the low).

Summary

Entrada posted a Q3 adjusted loss of $0.94 per share, better than the $1.01 consensus loss, but revenue fell 43.9% to $905 thousand against roughly $5.87 million expected — a wide miss on the top line. The quarterly net loss was $39.74 million. The company ended the period with $193.0 million in cash, which it says funds operations into Q4 2027, though the 10-Q carries a going-concern disclosure. This follows the positive ELEVATE-45-201 Cohort 1 topline data reported October 14, so the revenue shortfall is the number that matters here rather than the pipeline readout. Shares are down 50.8% year to date and closed at $5.06 ahead of the report.

At the time of this announcement, TRDA was trading at $4.59 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $178.7M. The 52-week trading range was $4.11 to $16.45. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

TRDA - Latest Insights

TRDA
Nov 18, 2026, 3:00 AM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $4.96
Real-time Price: $4.20 info
Change: -$0.760 (-15%) info
Market Cap: $170.304M info
TRDA
Oct 14, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $5.03
Real-time Price: $4.20 info
Change: -$0.830 (-17%) info
Market Cap: $170.304M info
TRDA
Aug 05, 2026, 7:11 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $7.25
Real-time Price: $4.20 info
Change: -$3.05 (-42%) info
Market Cap: $170.304M info
TRDA
Aug 05, 2026, 7:04 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $7.25
Real-time Price: $4.20 info
Change: -$3.05 (-42%) info
Market Cap: $170.304M info
TRDA
Jun 10, 2026, 4:06 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $5.80
Real-time Price: $4.20 info
Change: -$1.60 (-28%) info
Market Cap: $170.304M info